1THOMAS D A, O'BRIEN S, CORTES J, et al. Outcome with the hyper-CVAD regimens in lymphoblastic lymphoma[J]. Blood, 2004,104 : 1624 -- 1630.
2HOELZER D, GOKBUGET N, DIGEL W, et al. Outcome of adult patients with T-lymphoblastic lympho ma treated according to protocols for acute lympho blastic leukemia[J]. Blood, 2002,99:4379-- 4385.
3KANG W,HAHN J S,KIM J S,et al. Nine-year survival of lymphoblastic lymphoma patients[J]. Yonsei Med J,2006,47:466-474.
4CHEN Y C,HO C L,KAO W Y,et al. Adult lymphoblastic lymphoma in Taiwan: an analysis of treatment results of 26 patients[J]. Ann Hematol, 2001,80 : 647 --652.
6SONG K, BARNETT M, GASCOYNE R, et al. Primary therapy for adults with T-cell lymphoblastic lymphoma with hematopoietic stem-cell transplantation results in favorable outcomes [J]. Ann Oncol, 2007,18:535--540.
7SWEETENHAM J W, SANTINI G, QIAN W, et al. High-dose therapy and autologous stem-cell tran splantation versus conventional-dose consolidatiort/ maintenance therapy as postrernission therapy for adult patients with lymphoblastie lymphoma: results of a randomized trial of the European Group for Blod and Marow Transplantation and the United Kingdom Lymphoma Group[J]. J Clin Oncol, 2001,19: 2927 -- 2936.
8BUTCHER B W,COLLINS R H J R. The graft-versus-lymphoma effect:clinical review and future oppor tunities[J]. Bone Marrow Transplant, 2005, 36 : 1 - 17.
9LEVINE J E,HARRIS R E,LOBERIZA J R F R,et al. Acomparison of allogeneic and autologous bone marrow transplantation for lymphoblastic lymphoma [J]. Blood,2003,101:2476--2482.
1[1]Reiter A, Schrappe M, Ludwig WD, et al. Intensive ALL-type therapy without local radiotherapy provides a 90％ event-free survival for children with T-cell lymphoblastic lymphoma:a BFM group report [J]. Blood, 2000, 95(2):416-421.
2[2]Bouabdallah R, Xerri L, Bardou VJ, et al. Role of induction chemotherapy and bone marrow transplantation in adult lymphoblastic lymphoma: a report on 62 patients from a single center [J]. Ann Oncol, 1998, 9(6):619-625.
3[3]Reiter A, Schrappe M, Parwaresch R, et al. Non-Hodgkin's lymphomas of childhood and adolescence: results of a treatment stratified for biologic subtypes and stage-a report of the Berlin-Frankfurt-Munster Group [J]. J Clin Oncol, 1995，13(2):359-372.
4Armitage JO, Weisenburger DD. New approach to classifying nonHodgkin's lymphomas: clinical features of the major histologic subtypes. Non-Hodgkin's Lymphoma Classification Project. J Clin Oncol, 1998,16:2780-2795.
6Jaffe ES, Harris NL, Stein H, et al. WHO Classification of Tumours Pathology and Genetics of Haematopoietic and Lymphoid Tissues. Lyon: IARC Press, 2001.
7Hall PA, Richards MA, Gregory WM, et al. The prognostic value of Ki67 immunostaining in non-Hodgkin' s lymphoma. J Pathol, 1988,154:223.
8Thomas DA, Kantarjian HM. Lymphoblastic lymphoma. Hematol Oncol Clin North Am, 2001, 15:51-95.
9Suzumiya J,Ohshima K, Kikuchi M,et al. Terminal deoxynucleotide transferase staining of malignant lymphomas in paraffin sections: a useful method for the diagnosis of lymphoblastic lymphoma. J Pathol,1997,182:186.
10Braziel RM, Keneklis T, Donlon JA, et al. Terminal deoxynucleotide transferase in non-Hodgkin' s lymphoma. Am J Clin Pathol, 1983,80:655-659.
